학술논문
Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors
Document Type
Article
Author
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 15 November 2022, 28(22):4871-4884)
Subject
Language
English
ISSN
15573265
10780432
10780432